Judges

The Awards owe their success to the dedication, expertise, and brilliance of our judges, who represent various disciplines within the life sciences. Click on their images below to learn more about each one.

Dr. Jacqueline Barry

Chief Clinical Officer,
Cell and Gene Therapy Catapult

Dr. Jacqueline Barry

Chief Clinical Officer, Cell and Gene Therapy Catapult

Jacqueline Barry is the Chief Clinical Officer, responsible for Clinical Translation and Delivery activities and an Executive Director of the Cell and Gene Therapy Catapult. She has extensive experience in the development of advanced therapy medicinal products and leads a multi-disciplinary team of Nonclinical, Regulatory, Clinical Operations and Programme Management specialists. She also leads the coordination of the UK Advanced Therapy Treatment Centre Network and is a Director of the Global Alliance for iPSC Therapies.

She feels passionately about making advanced therapies available for patients and works closely with the MHRA and the NHS on the development of the ecosystems to support the adoption of these therapies.

Prior her time at Cell and Gene Therapy Catapult, Jacqueline worked at the Scottish National Blood Transfusion Service where amongst other activities she designed the regulatory strategy for the Cellular Therapies for the Blood Transfusion Service and acted as Qualified Person for their release. She has a PhD from the University of Aberdeen and did post-doctoral research in neurophysiology at the University of Edinburgh.

Dr. Kate Cameron

Founder & CEO, Cytochroma

Dr. Kate Cameron

Founder & CEO, Cytochroma

Kate founded Cytochroma after her successful career in academia. She is a driven entrepreneur and has achieved significant recognition in numerous international business awards, grants, and competitions. Cytochroma is a reagent and service company that commercialises human stem cell-based products and services to the pharmaceutical drug discovery market. The company is making a meaningful impact in drug discovery in critical areas, including obesity, diabetes, and cardiovascular disease.

Mark Cook

Chair,
Life Sciences Scotland ILG

Mark Cook

Chair, Life Sciences Scotland ILG
Chair, Teachers Pension Scheme
Chair, ABHI Scotland
Chair, Brain Health Scotland Life Sciences Limited
Trustee Jane Moore Trust

Mark has spent 30 years in roles within the health sector including biologicals/pharmaceuticals, medical technology and consultancy.

In February 2022 Mark became Co Chair of the Life Sciences Industrial Leadership Group in Scotland, he also continues to support decision making for non-medicine technologies through membership of the Scottish Health Technology Group plus, in conjunction with the Chief Scientist Office, raises the profile for the Life Sciences Sector in Scotland. Mark chairs a company working towards accelerating the cure for Alzheimer’s as well as looking after one of Scotland’s public pension schemes as its Independent Chair.

Life Science is a sector that is actively growing, will provide careers for our population at higher than average salaries, will increase the tax base of Scotland and do societal good by bringing forward innovative and transformational changes that will improve the health of our population.

Current focus for the Life Sciences ILG is the refresh of the sector strategy ( which runs until 2025 ) and Mark is leading on this having exceed our goal of £8 Billion generated by the Scottish Life Sciences sector by 2025 by over £2 billion 4 years early .

Prof. Dame
Anna Dominiczak

Regius Professor of Medicine and Chief Scientist (Health) for the Scottish Government.

Professor Dame Anna Dominiczak

Regius Professor of Medicine and Chief Scientist (Health) for the Scottish Government
Regius Professor of Medicine at the University of Glasgow.

Professor Dominiczak is a world-leading cardiovascular scientist and clinical academic. She has published extensively in top peer-reviewed journals (over 500 publications, an h-index of 122). Between 2010 and 2020 she was Vice-Principal and Head of the College of Medical, Veterinary and Life Sciences at the University of Glasgow. She was the driving force behind the fundraising, development and delivery of the University’s clinical academic campus at the Queen Elizabeth University Hospital, where she led a triple helix partnership between academia, the NHS, and industry to accelerate innovation, maximize patient benefits and economic growth.

Dame Anna is a member of several editorial boards and, from 2012 – 2022, was Editor-in-Chief of Hypertension, journal of the American Heart Association. Currently, she is Editor-in Chief of Precision Medicine, a new Prism journal of the Cambridge Press.

In March 2020, Anna led the establishment of Lighthouse Laboratory in Glasgow to provide rapid Covid–19 diagnostics, and then was asked to become Director of Laboratories at the UK Department of Health and Social Care to lead all 10 Lighthouse Laboratories across the UK, the role she fulfilled until 2022.

In July 2022 Professor Dominiczak was appointed as Chief Scientist (Health) for the Scottish Government, where she leads and coordinates health research and innovation, working in partnership with the NHS, academia and industry to develop rapid translation and adoption of transformative innovations for the Scottish NHS.

Dr. Alastair Florence

Professor at University of Strathclyde, Director of CMAC

Dr. Alastair Florence

Professor at University of Strathclyde, Director of CMAC

Alastair Florence is a distinguished professor in pharmaceutical sciences at the University of Strathclyde and is Director of CMAC, providing leadership across the portfolio, engaging with key stakeholders, and driving the centre’s vision to transform the development and manufacture of medicines.

Alastair leads a number of major programs across the portfolio including the new flagship EPSRC MediForge Industry 5.0 Manufacturing Hub, Centre for Doctoral Training in Cyber-physical systems (CEDAR) and the £33M UK-RPIF funded CMAC Data Lab partnership. He leads the multidisciplinary, multi-institution academic team driving ambitious manufacturing research, training, translation and facilities programs and working in close collaboration with industry partners to understand challenges and develop effective solutions across CMAC programs.

His research interests lie in the science and technology associated with continuous crystallization, physical form control and advanced characterization of pharmaceutical materials and the development of digital technologies to transform the development and manufacture of medicines.

Giles Hamilton

Board Member & Advisor

Giles Hamilton

Board Member & Advisor

Giles has started, grown, turned round & scaled companies through global partnerships to their work reaching patients

He has served on over 60 boards, received many awards for work in business & medical technology development and was elected FRSA in 1998

He works with BioTech & MedTech companies as a board member & advisor in Canada, UK & USA & on the Scottish Government Industry Leadership Group for Life Sciences.

Elaine Jamieson

Head of Life Sciences and Blue Economy, Highlands and Islands Enterprise

Highlands and Islands Enterprise (HIE) is the development agency for the Highlands and Islands of Scotland, an area that stretches from Shetland in the northeast to Kintyre and Arran in the southwest. The Highlands and Islands is a leading net zero region with a dynamic wellbeing economy, which benefits its growing population and makes a valued contribution to Scotland.

HIE recognises life sciences and the blue economy as regional transformational opportunities. Elaine leads on the development of major strategic and business prospects in these areas and supports HIE’s broader work with communities, enterprises and stakeholders to unlock our region’s potential for growth and progress, while driving fair work and net zero practices.

Elaine is a non-executive director of the Economic Development Association Scotland.

Elaine Jamieson

Head of Life Sciences and Blue Economy, Highlands and Islands Enterprise

Adam Liddle

Head of Sustainability, Roslin CT

Adam Liddle

Head of Sustainability, Roslin CT

Adam is Head of Sustainability with RoslinCT and brings with him 18 years of private and public sector experience of environmental regulation, sustainability consulting, and corporate sustainability leadership. Adam started his professional career as a chemist, later diversifying into environmental protection focusing on waste management, producer responsibility and transfrontier shipments of waste. Adam then spent 10 years in consultancy, advising private and public sector clients on strategic and technical application of resource efficiency and the circular economy, before developing and leading corporate sustainability strategies focused on delivering real impact for people and planet. Adam is an alumni of the University of Edinburgh and active member of numerous local, national and global sustainability working groups and has presented at various conferences and events including COP26, providing global representation for his employers. Adam is a Chartered Waste Manager and accredited Project Manager, a keen cyclist, father of two boys and lives in Portobello in Edinburgh.

Dr. Alison McIntosh

Director,
Scottish Universities Life Sciences Alliance (SULSA)

Dr. Alison McIntosh

Director, Scottish Universities Life Sciences Alliance (SULSA)

Alison McIntosh is the Director for the Scottish Universities Life Science Alliance (SULSA), which drives strategic collaboration across universities, disciplines and sectors. Within this role Alison works across the research and innovation ecosystem within the UK and abroad, driving collaborative research activities and strategic partnerships. Alison drives SULSA’s skills agenda, working in partnership with national agencies and organisations to support individual researchers and more broadly the life science skills pipeline. After obtaining her degree in Molecular Medicine at the University of Sussex, Alison undertook her PhD at the University of Edinburgh, using advanced microscopy to investigate molecular mechanisms at the cellular membrane. On completion of her PhD in 2013 Alison became the facility manager for the Edinburgh Super-Resolution Imaging Consortium (ESRIC) at Heriot-Watt University. Alison established ESRIC as a globally recognised centre of excellence for advanced microscopy, providing access to state-of-the-art microscopy equipment and the expertise to support high impact research. With a passion for driving collaboration and an interest in policy, Alison joined SULSA as Executive Director in March 2020 and became Director in October 2022. Alison supports the Scottish Research and Innovation agenda through positions on multiple committees including the SFC’s Research and Knowledge Exchange Committee, Universities Scotland’s Connected Scotland (international) committee and the Industry Leadership Group for Life Sciences.

Martin Sutcliffe

Innovation Lead Aquaculture for UK Agri-Tech Centre

Martin Sutcliffe

Martin Sutcliffe is the Innovation Lead for Aquaculture at the UK Agri-Tech Centre, Martin comes with a strong background in sustainable development within the aquaculture sector.

Passionate about marine environments, Martin has extensive experience in public aquariums, commercial aquaculture, and community-led projects. He has successfully delivered over 80 grant-funded initiatives and spearheaded the Dorset Mariculture Strategy.

Martin led the development of the concept for an Aquaculture Innovation Hub for England. The Hub is designed to develop a sustainable, thriving and diverse aquaculture sector in South West England and beyond.

Martin chaired the South West Aquaculture Network (SWAN) from its inception to January 2024, advancing innovation and cross-sector collaborations to promote a thriving aquaculture industry in the UK and beyond.

Jonathan Williamson

Chief Marketing Officer, Emblation

Jonathan Williamson

Jonathan Williamson is the Chief Marketing Officer at Emblation, an industry leader in medical microwave technology in the fields of oncology, dermatology and podiatry.

Jonathan joined Emblation in 2011 and is responsible for global marketing and international growth strategies. Since launching the Swift product for dermatology and podiatry in late 2016, the company have successfully introduced the technology into 22 markets worldwide and have more than 1500 systems in the field with 400,000 treatments completed.

Jonathan has more than 15 years of leadership experience in sales and marketing, communications, and organisational strategy. He holds an MA (Hons) in English Literature from the University of Glasgow, a Diploma from the Chartered Institute of Marketing, and a Masters in Strategy and Innovation from the University of Oxford. Jonathan is also Vice Chair of ABHI Scotland, the Scottish Member Group for the UK’s leading industry association for health technology.

Judges

Dr. Jacqueline Barry

Dr. Kate Cameron

Mark Cook

Prof. Dame
Anna Dominiczak

Dr. Alastair Florence

Giles Hamilton

Elaine Jamieson

Adam Liddle

Dr. Alison McIntosh

Martin Sutcliffe

Jonathan Williamson

When & Where

Contact

Produced by

Judges

Dr. Jacqueline Barry

Dr. Kate Cameron

Mark Cook

Prof. Dame Anna Dominiczak

Dr. Alastair Florence

Giles Hamilton

Elaine Jamieson

Adam Liddle

Dr. Alison McIntosh

Martin Sutcliffe

Jonathan Williamson

When & Where

Contact

Produced by

Prof. Dame
Anna Dominiczak